CCF-Fairview Hospital

Cleveland, Ohio 44111

0 studies enrolling now · 2 studies all time

What they study most

Lung Cancer, Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder

Studies at this site

• Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer — Stopped early
• Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Stopped early